EIR Juno Therapeutics May 2019

Sunitha Rajaram FDA$595.00 - Available Now

FDA investigators audited the Juno Therapeutics - Seattle, WA, United States facility and issued inspectional observation (via FDA 483) on 15 May 2019.

Product details

  • Category:
  • Inspection end: 15 May 2019
  • Location: Seattle, United States
  • FEI: 3010932912
Add To Cart